Golam Khandaker is Professor of Psychiatry at Bristol Medical School, Head of Immunopsychiatry and Experimental Medicine Programme at the MRC Integrative Epidemiology Unit, and Honorary Consultant Psychiatrist at the Avon and Wiltshire Mental Health Parthership NHS Trust. Golam's research focuses on identifying and validating novel immunological mechanisms and potential treatment targets for major psychiatric disorders particularly depression and schizophrenia using epidemiological cohort studies, genetic analysis, and early-phase clinical trials. The key impetus for this work is to move immunotherapies closer to psychiatric practice through innovative translational research. He is also interested in life-course epidemiology of mental disorders, physical and psychiatric multimorbidity especially aetiology, early detection, and prevention of cardiometabolic disease in people with schiozophrenia and depression, and use of routine clinical data for health research.